Exploring efficient and effective mammalian models for Alzheimer's disease
1Research Center for Global Agromedicine, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.
Frontiers in Aging Neuroscience
|September 2, 2025
Summary
This study explores efficient and effective mammalian models for Alzheimer's disease (AD). Promising candidates like marmosets and dogs, alongside understudied species, could advance AD research and treatment.
Area of Science:
- Neuroscience
- Animal Models
- Pathology
Background:
- Alzheimer's disease (AD) is a complex neurodegenerative disorder.
- Current AD models require refinement to fully recapitulate disease multifactoriality.
- Understanding AD requires models that exhibit core pathology and associated comorbidities.
Purpose of the Study:
- To identify and evaluate efficient and effective mammalian models for Alzheimer's disease (AD) research.
- To discuss criteria for ideal AD models, including pathology and systemic disturbances.
- To highlight underutilized species with potential for AD modeling.
Main Methods:
- Literature review and comparative analysis of existing and potential mammalian models for AD.
- Characterization of models based on efficiency (size, lifespan, pathology development) and effectiveness (co-pathology, systemic effects).
- Exploration of non-human primates, canines, tree shrews, guinea pigs, and degus as AD models.
Main Results:
- Efficient AD models display rapid amyloid plaque formation and short lifespans.
- Effective AD models mimic AD pathology, co-pathologies (e.g., Lewy body dementia), and systemic issues.
- Common marmosets and dogs show promise as effective AD models.
- Tree shrews, guinea pigs, and degus represent underexplored but potentially valuable models.
Conclusions:
- Mammalian models, including primates and canines, are crucial for advancing Alzheimer's disease (AD) research.
- Further investigation into species like tree shrews, guinea pigs, and degus may yield novel insights.
- Integrating diverse mammalian models with data science will accelerate AD prevention and treatment development.
Keywords:
amyloid-βblood brain barriercerebral amyloid angiopathydogmarmosetrodenttree shrewα-synucleinMore Related Videos
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
42.9K
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
27.1K
